JP2024523514A5 - - Google Patents

Info

Publication number
JP2024523514A5
JP2024523514A5 JP2023579198A JP2023579198A JP2024523514A5 JP 2024523514 A5 JP2024523514 A5 JP 2024523514A5 JP 2023579198 A JP2023579198 A JP 2023579198A JP 2023579198 A JP2023579198 A JP 2023579198A JP 2024523514 A5 JP2024523514 A5 JP 2024523514A5
Authority
JP
Japan
Prior art keywords
sequence
seq
identity
amino acid
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023579198A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024523514A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/101780 external-priority patent/WO2023274201A1/zh
Publication of JP2024523514A publication Critical patent/JP2024523514A/ja
Publication of JP2024523514A5 publication Critical patent/JP2024523514A5/ja
Pending legal-status Critical Current

Links

JP2023579198A 2021-06-28 2022-06-28 抗cd40抗体、その抗原結合断片及び医薬用途 Pending JP2024523514A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202110722124.0 2021-06-28
CN202110722124 2021-06-28
PCT/CN2022/101780 WO2023274201A1 (zh) 2021-06-28 2022-06-28 抗cd40抗体、其抗原结合片段及医药用途

Publications (2)

Publication Number Publication Date
JP2024523514A JP2024523514A (ja) 2024-06-28
JP2024523514A5 true JP2024523514A5 (cg-RX-API-DMAC7.html) 2025-07-07

Family

ID=84690362

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023579198A Pending JP2024523514A (ja) 2021-06-28 2022-06-28 抗cd40抗体、その抗原結合断片及び医薬用途

Country Status (11)

Country Link
US (1) US20250340661A1 (cg-RX-API-DMAC7.html)
EP (1) EP4365200A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024523514A (cg-RX-API-DMAC7.html)
KR (1) KR20240026185A (cg-RX-API-DMAC7.html)
CN (1) CN117295764A (cg-RX-API-DMAC7.html)
AU (1) AU2022301422A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023026111A2 (cg-RX-API-DMAC7.html)
CA (1) CA3223842A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023015070A (cg-RX-API-DMAC7.html)
TW (1) TW202309095A (cg-RX-API-DMAC7.html)
WO (1) WO2023274201A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024140917A1 (zh) * 2022-12-28 2024-07-04 上海盛迪医药有限公司 抗cd40抗体药物偶联物、其制备方法及其医药用途
CN120282801A (zh) 2022-12-28 2025-07-08 苏州盛迪亚生物医药有限公司 一种cd40结合分子的组合物及医药用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112536D0 (en) 1991-06-11 1991-07-31 Celltech Ltd Chemical compounds
US5397703A (en) * 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
US20030059427A1 (en) * 2000-04-28 2003-03-27 Force Walker R. Isolation and characterization of highly active anti-CD40 antibody
WO2002028481A2 (en) * 2000-10-02 2002-04-11 Chiron Corporation Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
AR039067A1 (es) * 2001-11-09 2005-02-09 Pfizer Prod Inc Anticuerpos para cd40
US7771951B2 (en) 2001-12-03 2010-08-10 Amgen Fremont Inc. Antibody categorization based on binding characteristics
GB0315450D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
PT1644412E (pt) 2003-07-01 2015-12-23 Ucb Biopharma Sprl Fragmentos de anticorpos fab modificados
GB0315457D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
US8277810B2 (en) 2003-11-04 2012-10-02 Novartis Vaccines & Diagnostics, Inc. Antagonist anti-CD40 antibodies
GB0411186D0 (en) 2004-05-19 2004-06-23 Celltech R&D Ltd Biological products
EP2535350B1 (en) 2007-09-26 2018-01-24 UCB Biopharma SPRL Dual specificity antibody fusions
US10407513B2 (en) 2008-09-26 2019-09-10 Ucb Biopharma Sprl Biological products
EP2796467B1 (en) * 2010-03-31 2018-03-28 Boehringer Ingelheim International GmbH Anti-CD40 antibodies
AR083847A1 (es) * 2010-11-15 2013-03-27 Novartis Ag Variantes de fc (fragmento constante) silenciosas de los anticuerpos anti-cd40
HUE065915T2 (hu) * 2011-03-11 2024-06-28 Beth Israel Deaconess Medical Ct Inc Anti-CD40 antitestek és alkalmazásaik
GB201115280D0 (en) * 2011-09-05 2011-10-19 Alligator Bioscience Ab Antibodies, uses and methods
US20170233485A1 (en) * 2014-08-18 2017-08-17 Biogen Ma Inc. Anti-cd40 antibodies and uses thereof
WO2017040932A1 (en) * 2015-09-04 2017-03-09 Primatope Therapeutics Inc. Humanized anti-cd40 antibodies and uses thereof
PE20181367A1 (es) * 2015-09-30 2018-08-27 Janssen Biotech Inc Anticuerpos agonistas que se unen especificamente a cd40 humana y metodos de uso
WO2018088850A2 (ko) * 2016-11-11 2018-05-17 다이노나(주) Cd40에 특이적으로 결합하는 항체 및 그의 용도
MX2019014375A (es) * 2017-06-01 2020-01-23 Jiangsu Hengrui Medicine Co Anticuerpo anti-cd40, fragmento de union a antigeno del mismo, y uso medico del mismo.
WO2020006347A1 (en) * 2018-06-29 2020-01-02 Boehringer Ingelheim International Gmbh Anti-cd40 antibodies for use in treating autoimmune disease
CN109912717B (zh) * 2019-03-04 2020-05-26 北京天广实生物技术股份有限公司 结合cd40的抗体及其用途

Similar Documents

Publication Publication Date Title
US9840554B2 (en) Antibodies against platelet-derived growth factor (PDGF)
RU2019140602A (ru) АНТИ-GARP-TGF-β-АНТИТЕЛА
JP2020528768A5 (cg-RX-API-DMAC7.html)
RU2016145277A (ru) Антитело против igf-1r и его применение в качестве адресующего переносчика для лечения рака
CN103459609A (zh) TNF-α结合蛋白
AU2014248636B2 (en) Humanized anti-N2 antibodies
AU2019233511B2 (en) Anti C-MET antibodies
JP2018510617A5 (cg-RX-API-DMAC7.html)
US12173081B2 (en) CD19/CD38 multispecific antibodies
MX2012011629A (es) Proteinas de union a tnf-alfa.
RU2019135404A (ru) Антитела для лечения инфекции гепатитом в и связанных с ней заболеваний
AU2019229663A1 (en) PD1 binding agents
JP2024540148A5 (cg-RX-API-DMAC7.html)
RU2018129180A (ru) Тромбиновое антитело, антиген-связывающий фрагмент и их фармацевтическое применение
WO2022204244A1 (en) Human ccl28 antibodies
US20230406942A1 (en) Igf1r antibodies
JP2023534779A5 (cg-RX-API-DMAC7.html)
JP2022548881A5 (cg-RX-API-DMAC7.html)
US20260028396A1 (en) Anti-myostatin antibodies and methods
WO2024088342A1 (en) Antibodies against cd24 and uses thereof
CN114437215B (zh) 抗人cd38抗体及其制备方法和用途
RU2024102543A (ru) Новые мультиспецифические молекулы
WO2026064762A1 (en) Anti-myostatin antibodies and methods
RU2021138202A (ru) Антитела против вируса гепатита в и их применение
KR20240139083A (ko) Btla에 대한 항체 및 이의 용도